Super Cialis is a premium pharmaceutical formulation combining Tadalafil’s proven efficacy with an optimized release profile, designed for men seeking reliable, long-lasting improvement in both erectile function and urinary symptoms associated with benign prostatic hyperplasia (BPH). As a next-generation phosphodiesterase type 5 (PDE5) inhibitor, it offers sustained therapeutic plasma concentrations, supporting spontaneous sexual activity and continuous relief from lower urinary tract symptoms. Its advanced pharmacokinetics reduce dosing frequency while maintaining clinical effectiveness, making it a cornerstone of modern urological and andrological practice.

Features

• Active ingredient: Tadalafil 20 mg (modified-release formulation)
• Mechanism: Selective inhibition of phosphodiesterase type 5 (PDE5)
• Duration of action: Up to 36 hours
• Onset of action: As early as 30 minutes post-administration
• Administration: Oral tablet, taken with or without food
• Packaging: Blister packs of 4, 8, or 12 tablets

Benefits

• Facilitates firm, sustainable erections sufficient for sexual intercourse with appropriate stimulation
• Provides continuous relief from BPH symptoms, including improved urinary flow and reduced nocturia
• Supports spontaneity in sexual activity due to extended duration of effect
• Reduces anxiety related to sexual performance through predictable pharmacokinetics
• Minimizes dosing frequency compared to shorter-acting alternatives
• Improves overall quality of life by addressing both sexual and urinary health concurrently

Common use

Super Cialis is indicated for the treatment of erectile dysfunction (ED) in adult males and for the signs and symptoms of benign prostatic hyperplasia (BPH). It is also approved for the concomitant treatment of ED and BPH when both conditions are present. Patients typically use Super Cialis on an as-needed basis prior to anticipated sexual activity, though daily low-dose regimens may be recommended for continuous BPH symptom management. Clinical studies demonstrate significant improvement in International Index of Erectile Function (IIEF) scores and maximal urinary flow rates (Qmax) compared to placebo.

Dosage and direction

For erectile dysfunction: The recommended dose is 20 mg taken at least 30 minutes before sexual activity. The maximum recommended dosing frequency is once per day. For benign prostatic hyperplasia: 5 mg taken once daily at approximately the same time each day. For concomitant ED and BPH: 5 mg once daily. Dosage adjustments may be necessary for patients with renal or hepatic impairment. Tablets should be swallowed whole with a glass of water; crushing or chewing may alter the release profile. Sexual stimulation is required for the erectogenic effect to occur.

Precautions

Patients should be counseled that Super Cialis offers no protection against sexually transmitted infections. Cardiovascular status should be assessed before prescribing, as sexual activity carries potential cardiac risk for those with preexisting heart disease. Priapism (erection lasting more than 4 hours) requires immediate medical attention to avoid permanent tissue damage. Caution is advised in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Alcohol consumption in moderation is generally acceptable but may increase the risk of orthostatic hypotension.

Contraindications

Super Cialis is contraindicated in patients using any form of organic nitrates or nitric oxide donors (e.g., amyl nitrite). Concomitant use with guanylate cyclase stimulators such as riociguat is prohibited. It is not recommended for patients with severe hepatic impairment (Child-Pugh Class C), end-stage renal disease requiring dialysis, or those with a history of non-arteritic anterior ischemic optic neuropathy (NAION). Hypersensitivity to tadalafil or any excipient in the formulation precludes use.

Possible side effects

Common adverse reactions (≥2%) include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and limb pain. These are typically mild to moderate and transient. Less frequently reported effects include dizziness, visual disturbances, gastroesophageal reflux, and palpitations. Serious but rare side effects include sudden hearing loss, priapism, and cardiovascular events in predisposed individuals. Most side effects are dose-dependent and may decrease with continued use.

Drug interaction

Concomitant use with alpha-blockers may potentiate hypotensive effects—dose adjustment or separation of administration may be necessary. Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) increase tadalafil exposure; dose reduction is recommended. Inducers of CYP3A4 (e.g., rifampin) may decrease efficacy. Antihypertensives may have additive blood pressure-lowering effects. Grapefruit juice may increase plasma concentrations and should be avoided.

Missed dose

For as-needed use: Take as soon as remembered if sufficient time remains before sexual activity. Do not double the dose. For daily use: Take the missed dose as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular schedule.

Overdose

Symptoms may include severe headache, dizziness, syncope, prolonged erection, and pronounced hypotension. Standard supportive measures should be employed, including supine positioning with legs elevated if hypotension occurs. Priapism requires urgent urological intervention. Hemodialysis is not expected to significantly enhance elimination due to high protein binding.

Storage

Store at room temperature (15–30°C) in the original blister packaging. Protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

Super Cialis is a prescription medication and should be used only under medical supervision. This information is for educational purposes and does not replace professional medical advice. Individual response may vary. Always consult a healthcare provider for diagnosis and treatment recommendations tailored to your specific health status.

Reviews

Clinical trials demonstrate patient satisfaction rates of 80-85% for erectile function improvement and significant reduction in BPH symptom scores. Real-world evidence supports sustained efficacy and tolerability over extended periods. Most users report improved confidence and relationship satisfaction. Common feedback highlights the convenience of the extended window of effectiveness compared to shorter-acting agents.